GAM
AGIO icon

Gotham Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History

Gotham Asset Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-4,851
Closed -$327K – 1122
2019
Q1 		$327K Buy
+4,851
New +$283K ﹤0.01% 969
2015
Q3 		– Sell
-10,967
Closed -$1.22M – 898
2015
Q2 		$1.22M Buy
+10,967
New +$1.18M 0.01% 602

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Gotham Asset Management's AGIO Position: Q2 2019 in Review

Gotham Asset Management sold out of Agios Pharmaceuticals (AGIO) in Q2 2019, closing a stake of 4,851 shares — an estimated $327K sold.

Gotham Asset Management first reported a position in AGIO in Q2 2015 and held it in 2 quarters. The position peaked at $1.22M in Q2 2015. 189 funds tracked by Wall St. Rank hold AGIO as of Q2 2019.

  • Gotham Asset Management reported no remaining Agios Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Gotham Asset Management sold 4,851 Agios Pharmaceuticals shares in Q2 2019, an estimated $327K.
  • Gotham Asset Management first reported a position in Agios Pharmaceuticals in Q2 2015 and held it in 2 quarters.
  • Gotham Asset Management's Agios Pharmaceuticals position peaked at $1.22M in Q2 2015.
  • 189 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2019.

Based on Gotham Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.